down arrow

Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
5,606.50
217.65 (4.04%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.13 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

5,388.855,625.00

52 Week

3,640.106,448.75
Valuation
Technical
Day's Volume

CASH

6.13 lacs (83.22%) Volume

Shareholding (Dec 2024)

FII

17.99%

Held by 720 FIIs

DII

20.54%

Held by 51 DIIs

Promoter

51.89%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 18.24%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Operating profit has grown by an annual rate 8.52% of over the last 5 years

 
4

Positive results in Dec 24

5

Stock is technically in a Mildly Bullish range

6

With ROE of 13.4, it has a Very Expensive valuation with a 10.4 Price to Book Value

7

High Institutional Holdings at 38.52%

8

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 148,835 Cr (Large Cap)

stock-summary
P/E

69.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.56%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

13.38%

stock-summary
Price to Book

10.43

Revenue and Profits (1 Year):
Net Sales:
2,319 Cr
(Quarterly Results - Dec 2024)
Net Profit:
589 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.56%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-8.71%
0%
-8.71%
1 Year
49.96%
0.76%
50.72%
2 Years
91.51%
1.83%
93.34%
3 Years
24.48%
2.13%
26.61%
4 Years
49.46%
2.72%
52.18%
5 Years
142.3%
4.73%
147.03%

Latest dividend: 30 per share ex-dividend date: Aug-02-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.48%
EBIT Growth (5y)
8.52%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.69
Tax Ratio
25.24%
Dividend Payout Ratio
49.69%
Pledged Shares
0
Institutional Holding
38.52%
ROCE (avg)
28.92%
ROE (avg)
18.24%
Valuation key factors
Factor
Value
P/E Ratio
69
Industry P/E
33
Price to Book Value
10.43
EV to EBIT
57.58
EV to EBITDA
49.60
EV to Capital Employed
13.78
EV to Sales
15.36
PEG Ratio
1.40
Dividend Yield
0.56%
ROCE (Latest)
21.46%
ROE (Latest)
13.38%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 35 Schemes (11.89%)

FIIs

Held by 720 FIIs (17.99%)

Promoter with highest holding

Nilima Prasad Divi (20.34%)

Highest Public shareholder

Life Insurance Corporation Of India (6.03%)

Individual Investors Holdings

7.32%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -0.81% vs 10.39% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 15.49% vs 18.60% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,319.00",
          "val2": "2,338.00",
          "chgp": "-0.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "743.00",
          "val2": "716.00",
          "chgp": "3.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "1.00",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "589.00",
          "val2": "510.00",
          "chgp": "15.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.04%",
          "val2": "30.62%",
          "chgp": "1.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 20.86% vs -10.27% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 33.52% vs -41.14% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,456.00",
          "val2": "3,687.00",
          "chgp": "20.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,339.00",
          "val2": "983.00",
          "chgp": "36.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "940.00",
          "val2": "704.00",
          "chgp": "33.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.05%",
          "val2": "26.66%",
          "chgp": "3.39%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 22.25% vs -4.73% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 43.97% vs -29.29% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,775.00",
          "val2": "5,542.00",
          "chgp": "22.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,082.00",
          "val2": "1,472.00",
          "chgp": "41.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,529.00",
          "val2": "1,062.00",
          "chgp": "43.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.73%",
          "val2": "26.56%",
          "chgp": "4.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 1.00% vs -13.31% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -12.28% vs -38.39% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,845.00",
          "val2": "7,767.00",
          "chgp": "1.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,205.00",
          "val2": "2,368.00",
          "chgp": "-6.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "1.00",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,600.00",
          "val2": "1,824.00",
          "chgp": "-12.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.11%",
          "val2": "30.49%",
          "chgp": "-2.38%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
2,319.00
2,338.00
-0.81%
Operating Profit (PBDIT) excl Other Income
743.00
716.00
3.77%
Interest
0.00
1.00
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
589.00
510.00
15.49%
Operating Profit Margin (Excl OI)
32.04%
30.62%
1.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -0.81% vs 10.39% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 15.49% vs 18.60% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
4,456.00
3,687.00
20.86%
Operating Profit (PBDIT) excl Other Income
1,339.00
983.00
36.22%
Interest
1.00
1.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
940.00
704.00
33.52%
Operating Profit Margin (Excl OI)
30.05%
26.66%
3.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 20.86% vs -10.27% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 33.52% vs -41.14% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6,775.00
5,542.00
22.25%
Operating Profit (PBDIT) excl Other Income
2,082.00
1,472.00
41.44%
Interest
1.00
1.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,529.00
1,062.00
43.97%
Operating Profit Margin (Excl OI)
30.73%
26.56%
4.17%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 22.25% vs -4.73% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 43.97% vs -29.29% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
7,845.00
7,767.00
1.00%
Operating Profit (PBDIT) excl Other Income
2,205.00
2,368.00
-6.88%
Interest
3.00
1.00
200.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,600.00
1,824.00
-12.28%
Operating Profit Margin (Excl OI)
28.11%
30.49%
-2.38%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 1.00% vs -13.31% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -12.28% vs -38.39% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Divis Laboratories Ltd stock-summary
stock-summary
Divis Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries. It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
Company Coordinates stock-summary
Company Details
1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli Hyderabad Telangana : 500032
stock-summary
Tel: 91-40-23786300/23786352/400
stock-summary
http://www.divislaboratories.com
stock-summary
mail@divislabs.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."